by Michael Fenimore | Oct 21, 2022 | Uncategorized
This interactive program updates learners on the latest guideline recommendations for biomarker identification and application in NSCLC. The program will enable learners to select appropriate personalized treatment pathways based on the tumor profile, while...
by Michael Fenimore | Oct 19, 2022 | Uncategorized
3.5-credit-hour educational curriculum that brings together 10 groups of 10 professionally connected clinicians led by an expert (called a Group Leader) to comprehensively review key information and best practices to help clinicians formulate their own practice action...
by Michael Fenimore | Oct 17, 2022 | Uncategorized
Diabetic retinopathy and diabetic macular edema affect a majority of patients with diabetes, but there are ways to mitigate its progression. You’ll learn practical strategies to help patients save their sight and you’ll discuss the integration of novel...
by Michael Fenimore | Sep 21, 2022 | Hematology-Oncology, Oncology
This research study explores the practices, beliefs, and priorities of health professionals treating Multiple Myeloma in order to identify key educational needs and interests. Through small, peer-led online groups, participating clinicians engage in self-assessments,...
by Michael Fenimore | Sep 7, 2022 | Uncategorized
Since the beginning of the COVID-19 pandemic, there have been reservations regarding the risks of using immunosuppressive or immunomodulating agents to treat patients with multiple sclerosis (MS) in case these treatments increase infectious disease risk or reduce...
